novo nordisk glp-1 receptor agonist weight management diabetes treatments Prescription Weight Loss Medications: How

Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study

The ADA notes that medication adjustments should be individualized based on the patient's glycemic control, with appropriate glucose monitoring during any interruption period

First review of the potential renoprotective effects and mechanisms of GLP-1R agonists and DPP-4 inhibitors in preclinical studies and in early clinical studies involving patients with diabetes

These medications belong to a class of glucagon-like peptide-1 (GLP-1) receptor agonists and are marketed under brand names such as Ozempic, Wegovy, Victoza, and Saxenda

31 Pharmacokinetics Exenatide concentration was evaluated by ELISA

10.1016/j.jdiacomp.2016.10.001 6 BirudarajuD.CherukuriL.KinningerA.DahalS.LakshmananS.RezvanizadehV.et al (2021)